3.6583
Orasure Technologies Inc stock is traded at $3.6583, with a volume of 458.34K.
It is up +4.89% in the last 24 hours and down -6.65% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$3.48
Open:
$3.58
24h Volume:
458.34K
Relative Volume:
0.49
Market Cap:
$273.39M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
5.081
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
-8.52%
1M Performance:
-6.65%
6M Performance:
-16.48%
1Y Performance:
-49.79%
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
OSUR
Orasure Technologies Inc
|
3.655 | 273.39M | 405.47M | 53.66M | 131.28M | 0.72 |
![]()
ISRG
Intuitive Surgical Inc
|
580.06 | 205.74B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
229.46 | 65.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
94.70 | 46.26B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
234.96 | 34.51B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
92.58 | 18.19B | 3.90B | 392.30M | 288.10M | 1.95 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-23 | Resumed | Evercore ISI | In-line |
Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
Aug-21-20 | Initiated | Evercore ISI | Outperform |
Aug-10-20 | Initiated | Citigroup | Buy |
Aug-10-20 | Initiated | JP Morgan | Neutral |
Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jun-25-20 | Initiated | Lake Street | Buy |
Apr-21-20 | Resumed | Stephens | Equal-Weight |
Oct-23-18 | Resumed | Raymond James | Mkt Perform |
Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
Nov-05-15 | Reiterated | Mizuho | Buy |
May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
Jan-23-15 | Reiterated | Mizuho | Buy |
Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
Jun-11-14 | Reiterated | Mizuho | Buy |
Dec-21-12 | Initiated | Mizuho | Buy |
Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
Manner Eglinton Increases Stake in OraSure Technologies Inc (OSU - GuruFocus.com
Orasure technologies director Nancy Gagliano buys $39,270 in shares - Investing.com
Orasure technologies CEO Carrie Eglinton Manner acquires $100,026 in shares - Investing.com
OraSure Technologies Executives Increase Holdings - TradingView
President of OraSure Technologies Carrie Eglinton Manner Buys 6.7% More Shares - Yahoo Finance UK
John P. Kenny Purchases 47,659 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) Stock - MarketBeat
Insider Buying: OraSure Technologies, Inc. (NASDAQ:OSUR) CEO Purchases 78,625 Shares of Stock - MarketBeat
Kenneth J. Mcgrath Purchases 64,000 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) Stock - MarketBeat
OraSure Technologies (NASDAQ:OSUR) Announces Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
Director’s Bold Move: Major Stock Purchase at Orasure Technologies - TipRanks
OraSure technologies CFO Kenneth J. McGrath buys $201,683 in common stock - Investing.com Canada
OraSure technologies CFO Kenneth J. McGrath buys $201,683 in common stock By Investing.com - Investing.com South Africa
Orasure technologies director Kenny John P. buys $151,217 in stock By Investing.com - Investing.com South Africa
Orasure technologies CEO purchases $247,377 in common stock - Investing.com India
Orasure technologies director Kenny John P. buys $151,217 in stock - Investing.com
OraSure Technologies Executives Increase Holdings with Recent Share Purchases - TradingView
Orasure technologies CEO purchases $247,377 in common stock By Investing.com - Investing.com UK
OraSure Technologies’ Earnings Call: Growth Amidst Challenges - TipRanks
OraSure Technologies, Inc. to Host Earnings Call - ACCESS Newswire
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2024 Earnings Call Transcript - Insider Monkey
Investors Don't See Light At End Of OraSure Technologies, Inc.'s (NASDAQ:OSUR) Tunnel And Push Stock Down 26% - Simply Wall St
Earnings call transcript: OraSure Q4 2024 revenue beats, stock drops post-earnings By Investing.com - Investing.com South Africa
OSUR stock touches 52-week low at $3.36 amid market challenges - Investing.com
Point-of-care testing strategies for syphilis, HIV and HCV - LabRoots
OSUROrasure Tech Latest Stock News & Market Updates - StockTitan
Citi cuts OraSure stock price target to $6, maintains buy rating - Investing.com
OraSure Technologies Inc (OSUR) Q4 2024 Earnings Call Highlights - GuruFocus.com
OraSure Technologies Inc (OSUR) Q4 2024 Earnings Call Highlights: Strong Core Revenue Growth ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q4 2024 Earnings Call Highlights: Strong Core Revenue Growth ... By GuruFocus - Investing.com Canada
Earnings call transcript: OraSure Q4 2024 revenue beats, stock drops post-earnings - Investing.com India
OraSure: Q4 Earnings Snapshot - The Advocate
OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
OraSure: Q4 Earnings Snapshot -February 25, 2025 at 05:18 pm EST - Marketscreener.com
OraSure Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
OraSure Technologies Reports Q4 2024 Financial Results - TipRanks
OraSure Reports Fourth Quarter 2024 Financial Results - GlobeNewswire
OraSure Technologies Inc (OSUR) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
OraSure Technologies (NASDAQ:OSUR) Lowered to Hold Rating by StockNews.com - MarketBeat
OraSure Technologies (OSUR) to Release Quarterly Earnings on Tuesday - Defense World
OraSure Technologies (OSUR) Projected to Post Earnings on Tuesday - MarketBeat
OraSure Technologies, Inc. (NASDAQ:OSUR) Short Interest Update - MarketBeat
Empowered Funds LLC Purchases 18,487 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Peapod Lane Capital LLC Invests $1.73 Million in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat
OraSure Technologies (NASDAQ:OSUR) Rating Lowered to "Hold" at StockNews.com - MarketBeat
Fed. Circ. Rejects COVID Test Suit In Gilstrap-Authored Ruling - Law360
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th - GlobeNewswire
OraSure Sets Date for Critical Q4 Financial Results: What's Next for the Diagnostics Giant? - StockTitan
OraSure Technologies (NASDAQ:OSUR) Rating Lowered to Hold at StockNews.com - Defense World
Drug Screening Market worth $19.5 billion by 2029 - The Globe and Mail
Its Stock Has Paid Off Big Time For Orasure Technologies Inc - SETE News
Potential Price Increase for Orasure Technologies Inc (OSUR) After Recent Insider Activity - Knox Daily
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orasure Technologies Inc Stock (OSUR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):